Soon Seog Jeong is a notable inventor based in Naperville, IL (US), recognized for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, he has made remarkable advancements in the development of therapeutic proteins and their applications.

Latest Patents

Among his latest patents, Soon Seog Jeong has developed thermostable variants of fibroblast growth factors. This technology relates to engineered human Fibroblast Growth Factor-2 (FGF2) proteins, which exhibit increased thermostability compared to the wild-type protein. The methods and compositions he has created are particularly useful in the culturing of embryonic stem cells. Another significant invention is the therapeutic apyrase constructs, which provide a new class of enhanced apyrases (EN-apyrases). These EN-apyrases possess superior pharmacokinetic, pharmacodynamic, and pharmacochemical properties, and can be purified using simplified procedures. The invention also includes constructs for transforming a cell to produce these EN-apyrases, which comprise sequences encoding a signal sequence, a linker, and a soluble apyrase.

Career Highlights

Throughout his career, Soon Seog Jeong has worked with various companies, including Apt Therapeutics, Inc. and Humanzyme Limited. His work in these organizations has contributed to the advancement of biotechnological innovations and therapeutic solutions.

Collaborations

He has collaborated with notable individuals in the field, including Ridong Chen and Timothy A Mitsky. These collaborations have further enhanced the impact of his inventions and research.

Conclusion

Soon Seog Jeong's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications and protein engineering.

This text is generated by artificial intelligence and may not be accurate.